K. Thomas Bailey has served as the chief financial officer of NanoString since January 2018.
Before joining NanoString, Tom was the chief financial officer at AgaMatrix Holdings LLC, a developer, manufacturer, and marketer of medical technologies for diabetes care. Before joining AgaMatrix, he served as chief executive officer and as chief financial officer of Angiotech Pharmaceuticals Inc., a developer, manufacturer, and marketer of local drug, drug delivery, and medical device technologies.
Tom also serves as a director of SCP Interventional Radiology LLC and The Homestretch Foundation and previously served as a director of AgaMatrix Holdings, Angiotech Pharmaceuticals, LifeCare Management Services, and OncoGenex Inc.
Tom received an AB in Economics from Harvard University and an MBA from Harvard Business School.